Results 271 to 280 of about 591,821 (395)

Phenotyping patients with chronic obstructive pulmonary disease and heart failure

open access: yesESC Heart Failure, Volume 12, Issue 2, Page 900-911, April 2025.
Central illustration. Abbreviations: ACEi, angiotensin‐converting enzyme inhibitor; ARB, angiotensin receptor blocker; ARNi, angiotensin‐receptor‐neprilysin inhibitor; CI, confidence interval; COPD, chronic obstructive pulmonary disease; CRT, cardiac resynchronization therapy; CV, cardiovascular; EF, ejection fraction; eGFR, estimated glomerular ...
Peter Moritz Becher   +12 more
wiley   +1 more source

TRPC channels contribute to endothelial dysfunction in pulmonary arterial hypertension. [PDF]

open access: yesRespir Res
Saint-Martin Willer A   +13 more
europepmc   +1 more source

Comparative performance of risk prediction indices for mortality or readmission following heart failure hospitalization

open access: yesESC Heart Failure, Volume 12, Issue 2, Page 1227-1236, April 2025.
Comparative performance of 7 risk prediction indices in patients hospitalized for heart failure. In this cohort of 1206 patients, the LENT index offered the greatest discrimination, calibration, and overall accuracy in predicting 30‐day composite all‐cause mortality or readmission following hospitalization for heart failure.
Tauben Averbuch   +8 more
wiley   +1 more source

Integrative Multiomics for Prognostic Assessment in Pulmonary Arterial Hypertension. [PDF]

open access: yesCirc Heart Fail
Pi H   +5 more
europepmc   +1 more source

Data Sheet 1_Safety of pericardiocentesis in pulmonary arterial hypertension: a systematic review.docx

open access: green
Maria Jose Cabada-Garcia (22073321)   +13 more
openalex   +1 more source

LONG-TERM FOLLOW UP AFTER SUCCESSFUL DISCONTINUATION OF PROSTACYCLIN ANALOGUES IN PATIENTS WITH PULMONARY ARTERIAL HYPERTENSION (PAH) [PDF]

open access: bronze, 2005
Enrique Diaz‐Guzman   +4 more
openalex   +1 more source

Longest survivor of pulmonary atresia with ventricular septal defect without surgical intervention

open access: yes
ESC Heart Failure, Volume 12, Issue 2, Page 1499-1507, April 2025.
Sang Zhou   +5 more
wiley   +1 more source

Long‐term cardiovascular outcomes of immune checkpoint inhibitor‐related myocarditis: A large single‐centre analysis

open access: yesESC Heart Failure, Volume 12, Issue 2, Page 1237-1245, April 2025.
Abstract Aims Immune checkpoint inhibitors (ICI) are the cornerstone of modern oncology; however, side effects such as ICI‐related myocarditis (irM) can be fatal. Recently, Bonaca proposed criteria for irM; however, it is unknown if they correlate well with cardiovascular (CV) ICI‐related adverse events.
Lorenzo Braghieri   +12 more
wiley   +1 more source

Platelet-Macrophage Aggregates in Remodeled Vessels of Patients With Pulmonary Arterial Hypertension. [PDF]

open access: yesPulm Circ
Farrell CL   +9 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy